cardiorenalmetabolic

R&D

Clinical Trials Round-Up: July/August 2026

While the volume of announcements hit a mid-year slump, July and August still produced an exciting array of updates across the drug development arena.

R&D

Concept of AI overview of patient in clinical trial

How AI simulation could help de-risk obesity and cardiometab...

AI life sciences models allow researchers to explore different patient populations, protocols, and development strategies before a study starts.

Patients

pharmaphorum podcast Episode, 260 - Ramy Younes, Boehringer Ingelheim

The cardio-renal-metabolic space and obesity as a chronic di...

The podcast welcomes Dr Ramy Younes, corporate VP, global head of clinical development, cardiorenalmetabolism, at Boehringer Ingelheim.

Clinical Trials Round-Up: July/August 2026

How AI simulation could help de-risk obesity and cardiometab...

The cardio-renal-metabolic space and obesity as a chronic di...

Flagship joins three biotechs together to form Etcelera

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks